Sophia Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Sophia Genetics SA
SOPH Stock  USD 5.17  0.08  1.52%   
Sophia Genetics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sophia Genetics' valuation are provided below:
Gross Profit
49.5 M
Profit Margin
(1.02)
Market Capitalization
356.2 M
Enterprise Value Revenue
4.6108
Revenue
73.3 M
We have found one hundred twenty available fundamental trend indicators for Sophia Genetics SA, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Sophia Genetics SA current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 220.6 M. Enterprise Value is estimated to decrease to about 165.8 M

Sophia Genetics Total Revenue

49.37 Million

Check Sophia Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sophia Genetics' main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Net Interest Income of 1.7 M or Interest Income of 4.1 M, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0 or PTB Ratio of 2.29. Sophia financial statements analysis is a perfect complement when working with Sophia Genetics Valuation or Volatility modules.
  
Build AI portfolio with Sophia Stock
Check out the analysis of Sophia Genetics Correlation against competitors.

Sophia Genetics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets186.4 M178.6 M127.3 M
Slightly volatile
Short and Long Term Debt Total36.3 M34.5 M14.6 M
Slightly volatile
Other Current Liabilities16.2 M18.7 M10.7 M
Slightly volatile
Total Current Liabilities26.7 M30.8 M18.8 M
Slightly volatile
Total Stockholder Equity141.6 M111 M93.7 M
Slightly volatile
Property Plant And Equipment Net15.1 M22.3 M10 M
Slightly volatile
Current Deferred Revenue4.6 M6.6 M3.3 M
Slightly volatile
Accounts Payable2 M2.2 M1.4 M
Slightly volatile
Cash110.7 M92.3 M78.7 M
Slightly volatile
Non Current Assets Total39.8 M64.3 M27.6 M
Slightly volatile
Non Currrent Assets Other3.5 M6.6 M2.2 M
Slightly volatile
Long Term Debt16 M15.2 M7.1 M
Slightly volatile
Cash And Short Term Investments128.5 M92.3 M86.6 M
Slightly volatile
Net Receivables9.7 M10 M7.2 M
Slightly volatile
Good Will9.1 M9.6 M8.1 M
Slightly volatile
Common Stock Total Equity2.3 M2.8 M2.2 M
Slightly volatile
Common Stock Shares Outstanding66.8 M75.6 M63.2 M
Pretty Stable
Liabilities And Stockholders Equity186.4 M178.6 M127.3 M
Slightly volatile
Non Current Liabilities Total38.7 M36.8 M16.1 M
Slightly volatile
Capital Lease Obligations12.1 M19.3 M8 M
Slightly volatile
Inventory5.2 M6.7 M4 M
Slightly volatile
Other Current Assets3.2 M5.3 M1.9 M
Slightly volatile
Other Stockholder Equity369.2 M542.3 M247.1 M
Slightly volatile
Total Liabilities44.8 M67.6 M33.6 M
Slightly volatile
Net Invested Capital145.7 M126.2 M99.1 M
Slightly volatile
Long Term Investments516.3 K891.2 K470.3 K
Slightly volatile
Property Plant And Equipment Gross17.1 M28.9 M11.2 M
Slightly volatile
Short and Long Term Debt2.6 M3.3 M2.4 M
Slightly volatile
Total Current Assets146.6 M114.3 M99.7 M
Slightly volatile
Capital Stock3.4 M4.8 M2.6 M
Slightly volatile
Non Current Liabilities Other368.8 K303.3 K697.8 K
Slightly volatile
Net Working Capital119.8 M83.5 M81 M
Slightly volatile
Short Term Debt2.2 M2 M2.5 M
Very volatile
Intangible Assets24.9 M23.8 M7.1 M
Slightly volatile
Common Stock3.4 M4.8 M2.6 M
Slightly volatile
Other Liabilities3.9 M2.6 M4.4 M
Slightly volatile
Net Tangible Assets148.3 M207.2 M80.2 M
Slightly volatile
Other Assets4.6 M7.2 M3 M
Slightly volatile
Deferred Long Term Liabilities12.8 K14.4 K15.7 K
Slightly volatile
Property Plant Equipment13.6 M24.6 M11.1 M
Slightly volatile

Sophia Genetics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income4.1 M3.9 M1.1 M
Slightly volatile
Depreciation And Amortization5.6 M9.9 M3.7 M
Slightly volatile
Interest Expense2.3 M2.2 M1.1 M
Slightly volatile
Selling General Administrative42.6 M54 M27.6 M
Slightly volatile
Selling And Marketing Expenses27.8 M33.8 M22.8 M
Slightly volatile
Total Revenue49.4 M74.9 M36.6 M
Slightly volatile
Gross Profit32.8 M50.5 M24.9 M
Slightly volatile
Other Operating Expenses117.3 M151.5 M84 M
Slightly volatile
Research Development30.6 M39.5 M21.9 M
Slightly volatile
Cost Of Revenue16.6 M24.4 M11.7 M
Slightly volatile
Total Operating Expenses100.7 M127.1 M72.2 M
Slightly volatile
Reconciled Depreciation5.6 M9.9 M3.7 M
Slightly volatile

Sophia Genetics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation10.3 M19 M5.4 M
Slightly volatile
Begin Period Cash Flow114.4 M141.7 M80.3 M
Slightly volatile
Other Cashflows From Financing Activities346.3 K364.5 K1.8 M
Very volatile
Depreciation5.6 M9.9 M3.7 M
Slightly volatile
Capital Expenditures7.5 M9.4 M5 M
Slightly volatile
End Period Cash Flow119.2 M92.3 M60.3 M
Slightly volatile
Change To Netincome15.8 M15 M5.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.393.5628.6659
Slightly volatile
PTB Ratio2.292.4129.4855
Slightly volatile
Days Sales Outstanding92.4155.97112
Slightly volatile
Book Value Per Share1.911.321.2186
Slightly volatile
Stock Based Compensation To Revenue0.140.230.0997
Slightly volatile
Capex To Depreciation1.61.091.5091
Slightly volatile
PB Ratio2.292.4129.4855
Slightly volatile
Inventory Turnover2.363.262.4759
Slightly volatile
Days Of Inventory On Hand140116153
Slightly volatile
Payables Turnover6.189.895.9788
Slightly volatile
Sales General And Administrative To Revenue0.670.650.7024
Slightly volatile
Research And Ddevelopement To Revenue0.690.610.6116
Slightly volatile
Capex To Revenue0.120.110.1291
Slightly volatile
Cash Per Share1.741.11.086
Slightly volatile
Days Payables Outstanding56.3938.1968.0132
Slightly volatile
Income Quality0.850.80.8674
Slightly volatile
Intangibles To Total Assets0.0960.170.1185
Pretty Stable
Net Debt To EBITDA1.190.890.8144
Slightly volatile
Current Ratio4.273.345.2369
Pretty Stable
Tangible Book Value Per Share1.660.920.9842
Slightly volatile
Receivables Turnover3.936.753.7437
Slightly volatile
Shareholders Equity Per Share1.911.321.2186
Slightly volatile
Debt To Equity0.190.360.1812
Pretty Stable
Capex Per Share0.0880.110.0758
Slightly volatile
Revenue Per Share0.590.890.5571
Slightly volatile
Interest Debt Per Share0.460.440.2263
Slightly volatile
Debt To Assets0.180.170.1202
Pretty Stable
Operating Cycle233172265
Slightly volatile
Price Book Value Ratio2.292.4129.4855
Slightly volatile
Days Of Payables Outstanding56.3938.1968.0132
Slightly volatile
Ebt Per Ebit1.121.061.0408
Very volatile
Company Equity Multiplier1.631.851.4734
Pretty Stable
Long Term Debt To Capitalization0.110.12060.0808
Slightly volatile
Total Debt To Capitalization0.150.270.1487
Pretty Stable
Debt Equity Ratio0.190.360.1812
Pretty Stable
Quick Ratio4.123.145.016
Pretty Stable
Net Income Per E B T0.80.920.9853
Slightly volatile
Cash Ratio3.242.694.2409
Slightly volatile
Cash Conversion Cycle176134197
Slightly volatile
Days Of Inventory Outstanding140116153
Slightly volatile
Days Of Sales Outstanding92.4155.97112
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.911.071.099
Very volatile
Price To Book Ratio2.292.4129.4855
Slightly volatile
Fixed Asset Turnover3.643.873.6936
Slightly volatile
Debt Ratio0.180.170.1202
Pretty Stable
Price Sales Ratio3.393.5628.6659
Slightly volatile
Asset Turnover0.320.480.4099
Slightly volatile
Gross Profit Margin0.530.610.6727
Slightly volatile
Price Fair Value2.292.4129.4855
Slightly volatile

Sophia Genetics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap220.6 M232.2 M787 M
Slightly volatile

Sophia Fundamental Market Drivers

Sophia Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sophia Genetics Financial Statements

Investors use fundamental indicators, such as Sophia Genetics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Sophia Genetics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue6.6 M4.6 M
Total Revenue74.9 M49.4 M
Cost Of Revenue24.4 M16.6 M
Stock Based Compensation To Revenue 0.23  0.14 
Sales General And Administrative To Revenue 0.65  0.67 
Research And Ddevelopement To Revenue 0.61  0.69 
Capex To Revenue 0.11  0.12 
Revenue Per Share 0.89  0.59 
Ebit Per Revenue(0.92)(0.97)

Currently Active Assets on Macroaxis

WDWalker Dunlop
GMGeneral Motors
GMGeneral Motors
BACBank of America
SSentinelOne
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:
How To Invest In Sophia
Details
Is Sophia Stock a good investment?
Details
What is Sophia Genetics' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Sophia Genetics Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is there potential for Health Care Equipment & Supplies market expansion? Will Sophia introduce new products? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
1.092
Quarterly Revenue Growth
0.228
Return On Assets
(0.26)
Return On Equity
(0.86)
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sophia Genetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY